Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Change in Accured Expenses (2010 - 2026)

Updated

Iovance Biotherapeutics (IOVA) posted Change in Accured Expenses of -$8.62 million for Q2 2026, compared with -$281,000 a year earlier.

Analysis

Iovance Biotherapeutics (IOVA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Iovance Biotherapeutics was -$2.99 million; for FY2025, it came in at $28.64 million, up 233.8% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
  • In prior years, Iovance Biotherapeutics' Change in Accured Expenses was $8.58 million in FY2024 (-56.6%), $19.77 million in FY2023, -$4.7 million in FY2022 and $20.68 million in FY2021 (-14.2%).
  • Quarterly Change in Accured Expenses has run from a low of -$23.02 million in Q1 2024 to a high of $21.17 million in Q4 2025 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in 1 of the last four quarters, with growth averaging 71.2%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2023, with growth of 934.7%; the weakest was Q4 2022, with a decline of 92.2%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$21.04 million (Q1 2026), $21.17 million (Q4 2025) and $5.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.96 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 1.20 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 338.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 222.50 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn -8.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.62 Mn
Mar 31, 2026 -21.04 Mn
Dec 31, 2025 21.17 Mn
Sep 30, 2025 5.50 Mn
Jun 30, 2025 -281,000.00
Mar 31, 2025 2.25 Mn
Dec 31, 2024 4.08 Mn
Sep 30, 2024 12.70 Mn
Jun 30, 2024 14.81 Mn
Mar 31, 2024 -23.02 Mn
Dec 31, 2023 9.41 Mn
Sep 30, 2023 15.93 Mn
Jun 30, 2023 3.49 Mn
Mar 31, 2023 -9.05 Mn
Dec 31, 2022 909,000.00
Sep 30, 2022 9.44 Mn
Jun 30, 2022 -9.89 Mn
Mar 31, 2022 -5.16 Mn
Dec 31, 2021 11.60 Mn
Sep 30, 2021 8.48 Mn
API Access

Iovance Biotherapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY